This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Hoffmann-La Roche Inc., Shionogi Company Limited. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2022-2024
Title: Takahiro Noda: Innovator in Influenza Prevention
Introduction
Takahiro Noda is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medicine, particularly in the prevention of influenza virus transmission. With a total of 2 patents, his work focuses on innovative methods to combat viral infections.
Latest Patents
One of Takahiro Noda's latest patents is a compound and method for the prevention of transmission of the influenza virus. This invention relates to a method for preventing transmission, which involves administering an effective amount of a compound to a patient infected with the influenza virus, referred to as the 'index patient'. The compound is designed to reduce the infectivity of the influenza virus in the index patient, thereby lowering the risk of triggering an influenza epidemic or pandemic. The method requires that the compound be administered to at least 10% of all influenza-infected individuals within a city's or country's population.
Career Highlights
Throughout his career, Takahiro Noda has worked with notable companies such as Hoffmann-La Roche Inc. and Shionogi Company Limited. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and research.
Collaborations
Takahiro Noda has collaborated with esteemed colleagues, including Takeshi Noshi and Ryu Yoshida. These partnerships have further enhanced his research and development efforts in the field of influenza prevention.
Conclusion
Takahiro Noda's innovative work in the prevention of influenza virus transmission showcases his dedication to improving public health. His contributions through patents and collaborations highlight the importance of research in combating viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile